中药活性成分抗呼吸系统疾病的作用与分子机制
该综述基于中医肺病理论,通过检索多个电子数据库确定临床高频中药,并利用TCMSP数据库分析口服生物利用度和类药性指数筛选活性成分。研究共从10种常见中药中鉴定出31种活性成分(如EGCG、山奈酚、异鼠李素、槲皮素、β-谷甾醇),并总结其在病毒与细菌感染、炎症、急性肺损伤、慢阻肺、肺纤维化、哮喘和肺癌中的药理作用与分子机制。
要点
- 从10种高频中药中鉴定出31种活性成分,如EGCG、槲皮素、山奈酚等。
- 活性成分主要调控NF-κB、Nrf2/HO-1、NLRP3、TGF-β/Smad、MAPK和PI3K/Akt/mTOR通路。
- 上述成分可抑制感染、炎症、细胞外基质沉积和肿瘤生长,覆盖多种肺病。
核心结论
- 综述表明所选中药的31种活性成分可通过调控多条信号通路抑制感染、炎症、细胞外基质沉积和肿瘤生长,为呼吸系统疾病的临床前研究与临床应用提供新视角。
研究设计与样本
- 综述类研究:基于中医肺病理论检索多个电子数据库确定临床高频中药,并利用TCMSP数据库分析口服生物利用度和类药性指数筛选活性成分。
- 共纳入10种常见中药,并从中鉴定出31种活性成分及其代谢物。
主要发现
- 从10种常见中药中鉴定出31种活性成分,包括EGCG、山奈酚、异鼠李素、槲皮素和β-谷甾醇等。
- 这些成分在病毒与细菌感染、炎症、急性肺损伤、慢阻肺、肺纤维化、哮喘和肺癌中表现出药理作用。
- 主要调控NF-κB、Nrf2/HO-1、NLRP3、TGF-β/Smad、MAPK和PI3K/Akt/mTOR通路。
- 通过上述通路抑制感染、炎症、细胞外基质沉积和肿瘤生长。
临床怎么用
- 为中医与中西医结合医生选用高频中药及其活性成分治疗呼吸系统疾病提供分子机制层面的参考。
- 提示EGCG、槲皮素、山奈酚等活性成分在抗感染、抗炎、抗纤维化和抗肿瘤方面具有潜在应用价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Respiratory diseases, especially the pandemic of respiratory infectious diseases and refractory chronic lung diseases, remain a key clinical issue and research hot spot due to their high prevalence rates and poor prognosis. In this review, we aimed to summarize the recent advances in the therapeutic effects and molecular mechanisms of key common bioactive compounds from Chinese herbal medicine. Based on the theories of traditional Chinese medicine related to lung diseases, we searched several electronic databases to determine the high-frequency Chinese medicines in clinical application. The active compounds and metabolites from the selected medicines were identified using the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) by analyzing oral bioavailability and drug similarity index. Then, the pharmacological effects and molecular mechanisms of the selected bioactive compounds in the viral and bacterial infections, inflammation, acute lung injury (ALI), chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, asthma, and lung cancer were summarized. We found that 31 bioactive compounds from the selected 10 common Chinese herbs, such as epigallocatechin-3-gallate (EGCG), kaempferol, isorhamnetin, quercetin, and β-sitosterol, can mainly regulate NF-κB, Nrf2/HO-1, NLRP3, TGF-β/Smad, MAPK, and PI3K/Akt/mTOR pathways to inhibit infection, inflammation, extracellular matrix deposition, and tumor growth in a series of lung-related diseases. This review provides novel perspectives on the preclinical study and clinical application of Chinese herbal medicines and their bioactive compounds against respiratory diseases.
引用
- Wang J, Wu Q, Ding L, et al. Therapeutic Effects and Molecular Mechanisms of Bioactive Compounds Against Respiratory Diseases: Traditional Chinese Medicine Theory and High-Frequency Use. Front Pharmacol. 2021. PMID: 34512360. doi:10.3389/fphar.2021.734450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。